Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
Clinical trial NCT02353871 · COMPLETED
Trial details
- NCT number
- NCT02353871
- Sponsor
- Ipsen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-04-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.